Hemoglobin Levels in Patients with Human Immunodeficiency Virus Na ve Therapy Containing Zidovudine in the First Three Months
Background: Zidovudine, one of the combination antiretroviral used to treat HIV/AIDS, is the most common cause of anemia in HIV patients. Anemia related to zidovudine in HIV can worsen HIV infection. This study determined the hemoglobin level and effect of zidovudine therapy on HIV naïve patients in...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article PeerReviewed |
Language: | English English English |
Published: |
EManuscript Technologies
2020
|
Subjects: | |
Online Access: | https://repository.unair.ac.id/126549/1/05%20artikel.pdf https://repository.unair.ac.id/126549/2/05%20Karil.pdf https://repository.unair.ac.id/126549/3/05%20Turnitin.pdf https://repository.unair.ac.id/126549/ https://www.sysrevpharm.org/abstract/hemoglobin-levels-in-patients-with-human-immunodeficiency-virus-nave-therapy-containing-zidovudine-in-the-first-three-mo-65525.html http://dx.doi.org/10.5530/srp.2019.2.04 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Universitas Airlangga |
Language: | English English English |
Internet
https://repository.unair.ac.id/126549/1/05%20artikel.pdfhttps://repository.unair.ac.id/126549/2/05%20Karil.pdf
https://repository.unair.ac.id/126549/3/05%20Turnitin.pdf
https://repository.unair.ac.id/126549/
https://www.sysrevpharm.org/abstract/hemoglobin-levels-in-patients-with-human-immunodeficiency-virus-nave-therapy-containing-zidovudine-in-the-first-three-mo-65525.html
http://dx.doi.org/10.5530/srp.2019.2.04